[1] risk factors associated with death among influenza a (h1n1) patients, tamil nadu, india, 2010

[2] CD206+ Cell Number Differentiates Influenza A (H1N1)pdm09 from Seasonal Influenza A Virus in Fatal Cases

[3] Antiviral activity of extracted fraction from camel urine against corona and influenza a (H1N1) viruses

[4] Virus Detection and Duration of Illness Among Patients With 2009 Pandemic Influenza A (H1N1) Virus Infection in Texas

[5] Household Transmission of 2009 Pandemic Influenza A (H1N1) and Nonpharmaceutical Interventions among Households of High School Students in San Antonio, Texas

[6] Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

[7] molecular characterization of severe and mild cases of influenza a (h1n1) 2009 strain from argentina caracterización molecular de cepas de influenza a (h1n1) 2009 de casos leves y graves de la argentina

[8] the impact of altitude on hospitalization and hospital mortality from pandemic 2009 influenza a (h1n1) virus pneumonia in mexico el impacto de la altitud en las tasas de hospitalización y mortalidad por el virus de la influenza a (h1n1) pandémico en méxico

[9] reacciones adversas a la vacuna contra influenza a (h1n1) en trabajadores de salud de una institución pública peruana

[10] perfil epidemiológico de la mortalidad por influenza humana a (h1n1) en méxico epidemiological profile of mortality due to human influenza a (h1n1) in mexico

[11] assessment of epicutaneous testing of a monovalent influenza a (h1n1) 2009 vaccine in egg allergic patients

[12] risco de uma pandemia de influenza pelo vírus a (h1n1) the risk of a pandemic with the influenza a (h1n1) virus

[13] risk factors associated with death among influenza a (h1n1) patients, tamil nadu, india, 2010

[14] combined interventions for mitigation of an influenza a (h1n1) 2009 outbreak in a physical training camp in beijing, china

[15] polymyositis following pandemic influenza a (h1n1) and 2009-10 seasonal trivalent vaccines

[16] report of a fatal pediatric case of hemophagocytic lymphohistiocytosis associated with pandemic influenza a (h1n1) infection in 2009

[17] prevalence of influenza a (h1n1) seropositivity in unvaccinated healthcare workers in scotland at the height of the global pandemic

[18] Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

[19] Serial Intervals and the Temporal Distribution of Secondary Infections within Households of 2009 Pandemic Influenza A (H1N1): Implications for Influenza Control Recommendations

[20] Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009

[21] Confirmation of the first Hong Kong case of human infection by novel swine origin influenza A (H1N1) virus diagnosed using ultrarapid, real-time reverse transcriptase PCR